1. Home
  2. WST vs BBD Comparison

WST vs BBD Comparison

Compare WST & BBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BBD
  • Stock Information
  • Founded
  • WST 1923
  • BBD 1943
  • Country
  • WST United States
  • BBD Brazil
  • Employees
  • WST N/A
  • BBD N/A
  • Industry
  • WST Medical/Dental Instruments
  • BBD Major Banks
  • Sector
  • WST Health Care
  • BBD Finance
  • Exchange
  • WST Nasdaq
  • BBD Nasdaq
  • Market Cap
  • WST 18.9B
  • BBD 30.6B
  • IPO Year
  • WST N/A
  • BBD N/A
  • Fundamental
  • Price
  • WST $256.66
  • BBD $3.30
  • Analyst Decision
  • WST Strong Buy
  • BBD Strong Buy
  • Analyst Count
  • WST 8
  • BBD 4
  • Target Price
  • WST $329.43
  • BBD $2.55
  • AVG Volume (30 Days)
  • WST 539.7K
  • BBD 36.0M
  • Earning Date
  • WST 10-23-2025
  • BBD 10-30-2025
  • Dividend Yield
  • WST 0.34%
  • BBD 4.70%
  • EPS Growth
  • WST N/A
  • BBD 58.81
  • EPS
  • WST 6.68
  • BBD 0.36
  • Revenue
  • WST $2,960,200,000.00
  • BBD $16,114,445,927.00
  • Revenue This Year
  • WST $6.28
  • BBD $72.65
  • Revenue Next Year
  • WST $6.02
  • BBD $8.90
  • P/E Ratio
  • WST $38.47
  • BBD $8.29
  • Revenue Growth
  • WST 2.90
  • BBD 27.09
  • 52 Week Low
  • WST $187.43
  • BBD $1.84
  • 52 Week High
  • WST $352.33
  • BBD $3.34
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.07
  • BBD 70.43
  • Support Level
  • WST $254.35
  • BBD $3.11
  • Resistance Level
  • WST $264.06
  • BBD $3.22
  • Average True Range (ATR)
  • WST 5.88
  • BBD 0.07
  • MACD
  • WST 0.41
  • BBD 0.01
  • Stochastic Oscillator
  • WST 66.99
  • BBD 89.47

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BBD Banco Bradesco Sa

Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.

Share on Social Networks: